Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125379331 | 12537933 | 1 | I | 20150619 | 20160624 | 20160707 | 20160707 | EXP | DE-TEVA-672063GER | TEVA | 1.00 | DY | M | Y | 1.48000 | KG | 20160707 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125379331 | 12537933 | 1 | SS | ZIPRASIDONE. | ZIPRASIDONE | 1 | Transplacental | 160 MILLIGRAM DAILY; | 0 | 80 | MG | BID | |||||||
| 125379331 | 12537933 | 2 | PS | SIMVASTATIN. | SIMVASTATIN | 1 | Transplacental | 20 MILLIGRAM DAILY; | 76052 | 20 | MG | QD | |||||||
| 125379331 | 12537933 | 3 | SS | leponex | CLOZAPINE | 1 | Transplacental | 300 MILLIGRAM DAILY; | 0 | 300 | MG | QD | |||||||
| 125379331 | 12537933 | 4 | SS | insidon | OPIPRAMOL HYDROCHLORIDE | 1 | Transplacental | 300 MILLIGRAM DAILY; | 0 | 100 | MG | TID | |||||||
| 125379331 | 12537933 | 5 | SS | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Transplacental | 20 MILLIGRAM DAILY; | 0 | 20 | MG | QD | |||||||
| 125379331 | 12537933 | 6 | SS | SEROQUEL | QUETIAPINE FUMARATE | 1 | Transplacental | DOSAGE UNKNOWN | 0 | ||||||||||
| 125379331 | 12537933 | 7 | C | FOLSAEURE | FOLIC ACID | 1 | Transplacental | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125379331 | 12537933 | 1 | Schizophrenia |
| 125379331 | 12537933 | 2 | Product used for unknown indication |
| 125379331 | 12537933 | 3 | Schizophrenia |
| 125379331 | 12537933 | 4 | Anxiety disorder |
| 125379331 | 12537933 | 5 | Product used for unknown indication |
| 125379331 | 12537933 | 6 | Schizophrenia |
| 125379331 | 12537933 | 7 | Prophylaxis of neural tube defect |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125379331 | 12537933 | CA |
| 125379331 | 12537933 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125379331 | 12537933 | Abnormal palmar/plantar creases | |
| 125379331 | 12537933 | Developmental delay | |
| 125379331 | 12537933 | Dysmorphism | |
| 125379331 | 12537933 | Foetal exposure during pregnancy | |
| 125379331 | 12537933 | Hyperbilirubinaemia neonatal | |
| 125379331 | 12537933 | Hypotonia neonatal | |
| 125379331 | 12537933 | Neonatal respiratory distress syndrome | |
| 125379331 | 12537933 | Premature baby | |
| 125379331 | 12537933 | Selective eating disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125379331 | 12537933 | 3 | 20141112 | 20150619 | 0 | |
| 125379331 | 12537933 | 4 | 20141112 | 20150619 | 0 | |
| 125379331 | 12537933 | 5 | 20141112 | 20150619 | 0 |